"Did You Know?" is a weekly feature from the Office for State, Tribal, Local and Territorial Support to inform your prevention activities. We invite you to read, share, and take action!
View the Current "Did You Know?"
June 13, 2014
- People of all ages with hemophilia are at risk for developing an inhibitor (or antibody) to the factor product used to treat or prevent bleeding episodes.
- Developing an inhibitor is a serious
complication of hemophilia, and those affected are twice as likely to be hospitalized for a bleeding-related problem.
- People with hemophilia should be tested regularly for inhibitors, and if possible, their care should be provided at a hemophilia treatment center.